... and Salaries of the Actors, Etc.; Sept. 1724-Juno, 1727. Two Volumes. Paper
0000 - Gale Group | NCCO British Theatre
Wenping Hu, Xinlong Dong, Zhilong Tian, Zhuangbiao Zhang, Jishun Tang, Benmeng Liang, Qiuyue Liu, Mingxing Chu,
Abstract Background JUNO and IZUMO1 are the first receptor-ligand protein pairs discovered to be essential for sperm-oocyte fusion; their ... clone the full-length DNA sequence of the Juno gene in sheep. The single nucleotide polymorphism (SNP) loci of Juno were genotyped by Sequenom MassARRAY®. PCR combined with ... to clone the full-length cDNA sequence of Juno and Izumo1 . Reverse transcriptase-PCR (RT-PCR) and ... used to analyze advanced structure and phylogeny of JUNO and IZUMO1 proteins. Results The full-length DNA ...
Tópico(s): Sperm and Testicular Function
2021 - BioMed Central | Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology
... and Salaries of the Actors, Etc.; Sept. 1724-Juno, 1727. Two Volumes. Paper
0000 - Gale Group | NCCO British Theatre
Jeremy S. Abramson, M. Lia Palomba, Leo I. Gordon, Matthew A. Lunning, Michael Wang, Jon Arnason, Enkhtsetseg Purev, David G. Maloney, Charalambos Andreadis, Alison R. Sehgal, Scott R. Solomon, Nilanjan Ghosh, Ana Kostić, Yeonhee Kim, K. OGASAWARA, Christine Dehner, Tanya Siddiqi,
... Rheos: Honoraria; Novartis: Consultancy; Lygenesis: Honoraria; Priothera: Honoraria; Juno: Patents & Royalties; Notch: Honoraria, Other: Stock; Pluto: Honoraria; ... Hebei Cancer Prevention Federation: Honoraria; Newbridge Pharmaceuticals: Honoraria; Juno: Consultancy, Research Funding; BioInvent: Research Funding; VelosBio: Consultancy, ... Funding; Acerta Pharma: Consultancy, Honoraria, Research Funding. Arnason: Juno/BMS: Honoraria. Maloney: Janssen: Honoraria; MorphoSys: Honoraria; Novartis: ... Hutchinson Cancer Research Center for patents licensed to Juno Therapeutics/Bristol Myers Squibb; BMS: Honoraria, Other: Rights ...
Tópico(s): CAR-T cell therapy research
2021 - Elsevier BV | Blood
... and Salaries of the Actors, Etc.; Sept. 1724-Juno, 1727. Two Volumes. Paper Business Record.
0000 - Gale Group | NCCO British Theatre
Lucrezia Colonna, Garnet Navarro, Todd DeVries, Valeria Beckett, Anthony Amsberry, Aditya Radhakrishnan, Julia Piasecki, Mark Heipel, Yan Li, Uma Kavita, Melissa Works, Mirna Mujacic,
... vivo proliferation, and in vivo persistence. Disclosures Colonna: Juno Therapeutics, a Bristol-Myers Squibb Company: Current Employment; ... Current equity holder in publicly-traded company. Navarro:Juno Therapeutics, a Bristol-Myers Squibb Company: Current Employment; ... Current equity holder in publicly-traded company. Devries:Juno Therapeutics, a Bristol-Myers Squibb Company: Current Employment; ... Company: Current equity holder in publicly-traded company; Juno Therapeutics, a Bristol-Myers Squibb Company: Current Employment. ...
Tópico(s): Biosimilars and Bioanalytical Methods
2020 - Elsevier BV | Blood
... and Salaries of the Actors, Etc.; Sept. 1724-Juno, 1727. Two Volumes. Paper
0000 - Gale Group | NCCO British Theatre
William G. Wierda, Kathleen A. Dorritie, Javier Muñoz, Deborah M. Stephens, Scott R. Solomon, Heidi H. Gillenwater, Lucy Gong, Lin Yang, K. OGASAWARA, Jerill Thorpe, Tanya Siddiqi,
... pharmacodynamic data will be reported. Table Disclosures Dorritie: Juno Therapeutics: Research Funding; Kite-Gilead: Research Funding. Munoz: ... a Gilead Company: Consultancy, Research Funding, Speakers Bureau; Juno/Celgene/BMS: Consultancy, Research Funding, Speakers Bureau; Janssen: ... Research Funding; Acerta: Research Funding; Gilead: Research Funding; Juno: Research Funding; MingSight: Research Funding; Arqule: Research Funding; Janssen: Consultancy; Pharmacyclics: Consultancy. Gillenwater:Juno Therapeutics, a Bristol-Myers Squibb Company: Current Employment; ...
Tópico(s): CAR-T cell therapy research
2020 - Elsevier BV | Blood
... and Salaries of the Actors, Etc.; Sept. 1724-Juno, 1727. Two Volumes. Paper
0000 - Gale Group | NCCO British Theatre
M. F. Vogt, J. E. P. Connerney, G. A. DiBraccio, Rob Wilson, M. F. Thomsen, R. W. Ebert, G. Clark, C. Paranicas, W. S. Kŭrth, F. Allegrini, P. W. Valek, S. J. Bolton,
... present a survey of reconnection events observed by Juno during its first 16 orbits of Jupiter (July 2016–October 2018). The events are identified using Juno magnetic field data, which facilitates comparison to the ... Galileo magnetometer data, but we present data from Juno's other particle and fields instruments for context. ... reversals and found 232 reconnection events in the Juno data, most of which featured an increase in | ... values. We found that most properties of the Juno reconnection events, like their spatial distribution and duration, ...
Tópico(s): Ionosphere and magnetosphere dynamics
2020 - Wiley | Journal of Geophysical Research Space Physics
... and Salaries of the Actors, Etc.; Sept. 1724-Juno, 1727. Two Volumes. Paper
0000 - Gale Group | NCCO British Theatre
Maria Lia Palomba, Leo I. Gordon, Tanya Siddiqi, Jeremy S. Abramson, Manali Kamdar, Matthew A. Lunning, David G. Maloney, Charalambos Andreadis, Jon Arnason, Nilanjan Ghosh, Amitkumar Mehta, Scott R. Solomon, Thalia A. Farazi, Jacob Garcia, Christine Dehner, K. OGASAWARA, Jie Gao, Michael Wang,
... in the MCL cohort. Disclosures Palomba: Pharmacyclics: Honoraria; Juno: Honoraria; Celgene: Honoraria; Merck: Honoraria; Novartis: Honoraria; Regeneron: Research Funding; Juno: Research Funding; Genentech: Research Funding. Gordon:Zylem Biosciences: Patents & Royalties: Patents, No Royalties. Siddiqi:Juno: Membership on an entity's Board of Directors ... Directors or advisory committees; BeiGene: Other: DMC member; Juno Therapeutics, Pharmacyclics LLC, an AbbVie Company, AstraZeneca, Celgene, ... AstraZeneca: Speakers Bureau; Pharmacyclics LLC, an AbbVie Company, Juno Therapeutics, KITE Pharma, AstraZeneca, TG Therapeutics, Celgene, Oncternal, ...
Tópico(s): Lymphoma Diagnosis and Treatment
2020 - Elsevier BV | Blood
... and Salaries of the Actors, Etc.; Sept. 1724-Juno, 1727. Two Volumes. Paper
0000 - Gale Group | NCCO British Theatre
Jeffrey Teoh, Timothy G. Johnstone, Brian Christin, Rachel Yost, Neil A. Haig, Mary Mallaney, Aditya Radhakrishnan, Heidi H. Gillenwater, Tina Albertson, Paul Guptill, Lauren F. Brown, Christopher G. Ramsborg, Ronald J. Hause, Ryan Larson,
... efficiency and scalability for commercial production. Disclosures Teoh: Juno Therapeutics, a Celgene Company: Employment, Equity Ownership. Johnstone:Juno Therapeutics, a Celgene Company: Employment, Patents & Royalties: Author ... disclosures relating to cell therapy and immunosequencing. Christin:Juno Therapeutics, a Celgene Company: Employment, Equity Ownership. Yost:Juno Therapeutics, a Celgene Company: Employment, Equity Ownership. Haig:Juno Therapeutics, a Celgene Company: Employment, Equity Ownership. Mallaney: ...
Tópico(s): Biosimilars and Bioanalytical Methods
2019 - Elsevier BV | Blood
... and Salaries of the Actors, Etc.; Sept. 1724-Juno, 1727. Two Volumes. Paper Business Record.
0000 - Gale Group | NCCO British Theatre
Jeremy S. Abramson, Maria Lia Palomba, Leo I. Gordon, Matthew A. Lunning, Michael Wang, Jon Arnason, Amitkumar Mehta, Enkhtsetseg Purev, David G. Maloney, Charalambos Andreadis, Alison R. Sehgal, Scott R. Solomon, Nilanjan Ghosh, Tina Albertson, Jacob Garcia, Ana Kostić, D. Li, Yeonhee Kim, Tanya Siddiqi,
... Inc, Genentech, Gilead Sciences Inc, Janssen Biotech Inc, Juno Therapeutics, a Celgene Company, Karyopharm Therapeutics, Kite Pharma ... committees; Merck & Co Inc.: Consultancy; MSK (IP for Juno and Seres): Patents & Royalties; Noble Insights: Consultancy; Pharmacyclics: ... Gilead: Other: Advisory Board; Bayer: Other: Advisory Board; Juno/Celgene: Other: Advisory Board, Research Funding; Zylem LLC: ... TG Therapeutics: Consultancy, Research Funding; MiRagen: Research Funding; Juno Therapeutics: Consultancy, Research Funding; Janssen Scientific Affairs, LLC: ...
Tópico(s): Biosimilars and Bioanalytical Methods
2019 - Elsevier BV | Blood
... and Salaries of the Actors, Etc.; Sept. 1724-Juno, 1727. Two Volumes. Paper
0000 - Gale Group | NCCO British Theatre
Christine Jean, Farahd Haghighirad, Yingzi Zhu, M Chalbi, Ahmed Ziyyat, Eric Rubinstein, Christine Gourier, Paul S. F. Yip, Jean Philippe Wolf, Jeffrey E. Lee, Claude Boucheix, Virginie Barraud‐Lange,
Is JUNO protein present at the surface membrane of human oocytes and involved in the fertilisation process?JUNO protein is expressed on the plasma membrane of ... the oocyte, Izumo1 protein on the sperm and Juno, its corresponding receptor on the oocyte. Oocyte CD9 ... conserved among several mammalian species. The presence of JUNO on human oocytes, however, has not yet been ... fertilisation been investigated.We selected an anti-human JUNO antibody in order to investigate the presence of JUNO on the oocyte membrane surface and studied its ...
Tópico(s): RNA Interference and Gene Delivery
2018 - Oxford University Press | Human Reproduction
... and Salaries of the Actors, Etc.; Sept. 1724-Juno, 1727. Two Volumes. Paper
0000 - Gale Group | NCCO British Theatre
Tanya Siddiqi, Jeremy S. Abramson, D. Li, William Brown, Todd DeVries, Kedar Dave, Jacob Garcia, Maria Lia Palomba, Leo I. Gordon, Matthew A. Lunning, Jon Arnason, Michael Wang, Andres Forero‐Torres, David G. Maloney, Tina Albertson, Claire L. Sutherland,
... and potentially improve durability of response. Disclosures Siddiqi: Juno: Other: Steering committee for JCAR017; Seattle Genetics: Speakers ... Consultancy; Novartis: Consultancy; LAM Therapeutics: Research Funding. Li: Juno Therapeutics: Employment, Equity Ownership. Brown: Juno Therapeutics: Employment. Devries: Juno Therapeutics: Employment. Dave: Juno Therapeutics: Employment, Equity Ownership. Garcia: Juno Therapeutics, Inc.: Employment, Equity Ownership. Gordon: Janssen: Other: ... Committee. Lunning: Onyx: Consultancy; Genentech: Consultancy; Epizyme: Consultancy; Juno: Consultancy; BMS: Consultancy; TG Therapeutics: Consultancy; Celgene: Consultancy; ...
Tópico(s): Biosimilars and Bioanalytical Methods
2017 - Elsevier BV | Blood
... and Salaries of the Actors, Etc.; Sept. 1724-Juno, 1727. Two Volumes. Paper
0000 - Gale Group | NCCO British Theatre
Banri Suzuki, Yukou Sugano, Jun Ito, Haruka Saito, Sueo NIIMURA, Hideaki Yamashiro,
... sperm interaction is the essential step in fertilization. Juno, which has been known as Folate receptor 4, ... aims to investigate the location and expression of Juno in mice oocytes during maturation.To confirm the stage at which Juno expression begins in the mice oocytes and its ... pattern, we performed immunostaining methods. Next, we evaluated Juno mRNA expression by a half quantitative RT-PCR. Juno knockdown oocytes were generated by microinjecting siRNA into ... analyzed the maturation rate.Our results showed that Juno was expressed on the surface of the oocyte ...
Tópico(s): Urological Disorders and Treatments
2017 - Brazilian Society of Assisted Reproduction | JBRA
... and Salaries of the Actors, Etc.; Sept. 1724-Juno, 1727. Two Volumes. Paper
0000 - Gale Group | NCCO British Theatre
Christopher G. Ramsborg, Paul Guptill, Clinton Weber, Brian Christin, Ryan Larson, K.L. Lewis, Mary Mallaney, Michael A. Bowen, Eileen M. Higham, Tina Albertson,
... products in clinical development for NHL. Disclosures Ramsborg: Juno Therapeutics: Employment, Equity Ownership, Patents & Royalties. Guptill: Juno Therapeutics: Employment, Equity Ownership. Weber: Juno Therapeutics: Employment, Equity Ownership. Christin: Juno Therapeutics: Employment, Equity Ownership. Larson: Juno Therapeutics: Employment, Equity Ownership, Patents & Royalties. Lewis: Juno Therapeutics: Employment, Equity Ownership. Mallaney: Juno Therapeutics: Employment, Equity Ownership. Bowen: Juno Therapeutics: Employment, ...
Tópico(s): Biosimilars and Bioanalytical Methods
2017 - Elsevier BV | Blood
... and Salaries of the Actors, Etc.; Sept. 1724-Juno, 1727. Two Volumes. Paper
0000 - Gale Group | NCCO British Theatre
Kim Harrington, Rebecca Wu, Collin Hauskins, Rupesh P. Amin, Thomas Long, Aye Chen, Ayu Rahardjo, C. G. Thayer, Garnet Navvaro, Madelyn Myers, Jon C. Jones, Alex Baturevych, Stan Morkowski, Ruth A. Salmon, Christopher J. Bond, Mette Stæhr, Terence J. Purdon, Reed Masakayan, Liu C, Hong Liu, Yiyang Xu, Pei Wang, Margot J. Pont, Damian J. Green, Renier J. Brentjens, Eric L. Smith, Blythe Sather,
... no observed off target effects reported to date. Juno Therapeutics is developing a (CAR) T-cell product ... JCARH125, are planned for early 2018. Disclosures Harrington: Juno Therapeutics: Employment, Equity Ownership. Hauskins: Juno therapeutics: Employment, Equity Ownership. Amin: Juno therapeutics: Employment, Equity Ownership. Long: Juno Therapeutics, Inc.: Employment, Equity Ownership. Chen: Juno Therapeutics: Employment, Equity Ownership. Rahardjo: Juno Therapeutics: Employment, Equity Ownership. Thayer: Juno Therapeutics: Employment, ...
Tópico(s): Monoclonal and Polyclonal Antibodies Research
2017 - Elsevier BV | Blood
... and Salaries of the Actors, Etc.; Sept. 1724-Juno, 1727. Two Volumes. Paper
0000 - Gale Group | NCCO British Theatre
Ling Han, Kaoru Nishimura, Hamed Sadat Al Hosseini, Enrica Bianchi, Gavin J. Wright, Luca Jovine,
... the identification of the glycosylphosphatidylinositol (GPI)-anchored glycoprotein Juno as the egg plasma membrane receptor of sperm ... E. Doe B. Goulding D. Wright G.J. Juno is the egg Izumo receptor and is essential ... 466-467Crossref PubMed Scopus (11) Google Scholar]. The Juno–Izumo1 interaction was shown to be essential for ... E. Doe B. Goulding D. Wright G.J. Juno is the egg Izumo receptor and is essential ... interact at fertilization, and it is unclear how Juno — which was previously named folate receptor (FR) 4, ...
Tópico(s): Animal Genetics and Reproduction
2016 - Elsevier BV | Current Biology
... and Salaries of the Actors, Etc.; Sept. 1724-Juno, 1727. Two Volumes. Paper
0000 - Gale Group | NCCO British Theatre